First Time Loading...
A

Aurisco Pharmaceutical Co Ltd
SSE:605116

Watchlist Manager
Aurisco Pharmaceutical Co Ltd
SSE:605116
Watchlist
Price: 24.41 CNY -1.41% Market Closed
Updated: Apr 30, 2024

Aurisco Pharmaceutical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aurisco Pharmaceutical Co Ltd
Operating Income Peer Comparison

Comparables:
C
1093
H
3692
600436
600276
000538

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
A
Aurisco Pharmaceutical Co Ltd
SSE:605116
Operating Income
¥215.7m
CAGR 3-Years
9%
CAGR 5-Years
20%
CAGR 10-Years
N/A
C
CSPC Pharmaceutical Group Ltd
HKEX:1093
Operating Income
¥7.7B
CAGR 3-Years
12%
CAGR 5-Years
16%
CAGR 10-Years
23%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Operating Income
¥3.7B
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Operating Income
¥3.3B
CAGR 3-Years
22%
CAGR 5-Years
22%
CAGR 10-Years
21%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Operating Income
¥3.6B
CAGR 3-Years
-17%
CAGR 5-Years
-3%
CAGR 10-Years
10%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Operating Income
¥3.7B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
6%

See Also

What is Aurisco Pharmaceutical Co Ltd's Operating Income?
Operating Income
215.7m CNY

Based on the financial report for Dec 31, 2022, Aurisco Pharmaceutical Co Ltd's Operating Income amounts to 215.7m CNY.

What is Aurisco Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
20%

Over the last year, the Operating Income growth was 12%. The average annual Operating Income growth rates for Aurisco Pharmaceutical Co Ltd have been 9% over the past three years , 20% over the past five years .